Suppr超能文献

化学预防和疫苗接种在预防脑膜炎球菌病病例家庭接触者后续脑膜炎球菌病病例中的作用:一项系统评价

Chemoprophylaxis and vaccination in preventing subsequent cases of meningococcal disease in household contacts of a case of meningococcal disease: a systematic review.

作者信息

Telisinghe L, Waite T D, Gobin M, Ronveaux O, Fernandez K, Stuart J M, Scholten R J P M

机构信息

Field Epidemiology Services,Public Health England,Bristol,UK.

World Health Organization,Geneva,Switzerland.

出版信息

Epidemiol Infect. 2015 Aug;143(11):2259-68. doi: 10.1017/S0950268815000849. Epub 2015 Apr 28.

Abstract

Household contacts of an index case of invasive meningococcal disease (IMD) are at increased risk of acquiring disease. In revising WHO guidance on IMD in sub-Saharan Africa, a systematic review was undertaken to assess the effect of chemoprophylaxis and of vaccination in preventing subsequent cases of IMD in household contacts following an index case. A literature search for systematic reviews identified a single suitable review on chemoprophylaxis in 2004 (three studies meta-analysed). A search for primary research papers published since 2004 on chemoprophylaxis and without a date limit on vaccination was therefore undertaken. There were 2381 studies identified of which two additional studies met the inclusion criteria. The summary risk ratio for chemoprophylaxis vs. no chemoprophylaxis (four studies) in the 30-day period after a case was 0·16 [95% confidence interval (CI) 0·04-0·64, P = 0·008]; the number needed to treat to prevent one subsequent case was 200 (95% CI 111-1000). A single quasi-randomized trial assessed the role of vaccination. The risk ratio for vaccination vs. no vaccination at 30 days was 0·11 (95% CI 0·01-2·07, P = 0·14). The results support the use of chemoprophylaxis to prevent subsequent cases of IMD in household contacts of a case. Conclusions about the use of vaccination could not be drawn.

摘要

侵袭性脑膜炎球菌病(IMD)首例病例的家庭接触者感染该病的风险增加。在修订世界卫生组织关于撒哈拉以南非洲地区IMD的指南时,开展了一项系统评价,以评估化学预防和疫苗接种对预防首例病例后家庭接触者中后续IMD病例的效果。对系统评价进行的文献检索发现了2004年一项关于化学预防的合适评价(对三项研究进行了荟萃分析)。因此,对2004年以来发表的关于化学预防且对疫苗接种无时间限制的原始研究论文进行了检索。共识别出2381项研究,其中另有两项研究符合纳入标准。病例发生后30天内,化学预防与未进行化学预防(四项研究)的汇总风险比为0·16[95%置信区间(CI)0·04 - 0·64,P = 0·008];预防一例后续病例所需治疗人数为200(95%CI 111 - 1000)。一项单组半随机试验评估了疫苗接种的作用。30天时疫苗接种与未接种疫苗的风险比为0·11(95%CI 0·01 - 2·07,P = 0·14)。结果支持使用化学预防措施来预防病例家庭接触者中的后续IMD病例。关于疫苗接种使用的结论尚无法得出。

相似文献

4
Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.用于预防A群脑膜炎球菌性脑膜炎的多糖疫苗。
Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD001093. doi: 10.1002/14651858.CD001093.pub2.
5
Antibiotics for preventing meningococcal infections.预防脑膜炎球菌感染的抗生素。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD004785. doi: 10.1002/14651858.CD004785.pub3.
6
Antibiotics for preventing meningococcal infections.用于预防脑膜炎球菌感染的抗生素。
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004785. doi: 10.1002/14651858.CD004785.pub2.
8
Antibiotics for preventing meningococcal infections.用于预防脑膜炎球菌感染的抗生素。
Cochrane Database Syst Rev. 2013 Oct 25;2013(10):CD004785. doi: 10.1002/14651858.CD004785.pub5.
9
Vaccines for preventing infections in adults with solid tumours.用于预防实体瘤成年患者感染的疫苗。
Cochrane Database Syst Rev. 2025 Apr 16;4(4):CD015551. doi: 10.1002/14651858.CD015551.pub2.

引用本文的文献

本文引用的文献

2
Antibiotics for preventing meningococcal infections.用于预防脑膜炎球菌感染的抗生素。
Cochrane Database Syst Rev. 2013 Oct 25;2013(10):CD004785. doi: 10.1002/14651858.CD004785.pub5.
10
A surveillance network for meningococcal disease in Europe.欧洲的脑膜炎球菌病监测网络。
FEMS Microbiol Rev. 2007 Jan;31(1):27-36. doi: 10.1111/j.1574-6976.2006.00060.x. Epub 2006 Dec 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验